188 related articles for article (PubMed ID: 31725619)
1. Denosumab and Sunitinib in the treatment of giant-cell tumor of bone with pulmonary and bone metastases in an adolescent: A case report.
Wang G; Jiang S; Li Z; Dong Y
Medicine (Baltimore); 2019 Nov; 98(46):e17778. PubMed ID: 31725619
[TBL] [Abstract][Full Text] [Related]
2. Can Denosumab cure giant cell tumors of the spine? A case report and literature review.
Xará-Leite F; Coutinho L; Fleming C; Magalhães M; Oliveira V; Rodrigues-Pinto R; Cardoso P
Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):19-23. PubMed ID: 31529151
[TBL] [Abstract][Full Text] [Related]
3. Morphological Transformation of Giant-Cell Tumor of Bone After Treatment with Denosumab: A Case Report.
Zhang Y; Ilaslan H; Krishnaney AA; Bauer TW
JBJS Case Connect; 2016; 6(3):e74. PubMed ID: 29252651
[TBL] [Abstract][Full Text] [Related]
4. The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature.
Al Farii H; McChesney G; Patel SS; Rhines LD; Lewis VO; Bird JE
Spine J; 2024 Jun; 24(6):1056-1064. PubMed ID: 38301904
[TBL] [Abstract][Full Text] [Related]
5. Combining two-stage surgery and denosumab treatment in a patient with giant cell tumour of the lumbar spine with intraperitoneal growth.
Liu S; Zhou X; Song A; Huo Z; Wang Y; Liu Y
Postgrad Med J; 2019 Feb; 95(1120):106-107. PubMed ID: 30425137
[No Abstract] [Full Text] [Related]
6. Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
Palmerini E; Chawla NS; Ferrari S; Sudan M; Picci P; Marchesi E; Leopardi MP; Syed I; Sankhala KK; Parthasarathy P; Mendanha WE; Pierini M; Paioli A; Chawla SP
Eur J Cancer; 2017 May; 76():118-124. PubMed ID: 28324746
[TBL] [Abstract][Full Text] [Related]
7. Denosumab Treatment for Giant Cell Tumor of the Spine Including the Sacrum.
Bukata SV; Blay JY; Rutkowski P; Skubitz K; Henshaw R; Seeger L; Dai T; Jandial D; Chawla S
Spine (Phila Pa 1976); 2021 Mar; 46(5):277-284. PubMed ID: 33038190
[TBL] [Abstract][Full Text] [Related]
8. Recurrent giant cell tumour of the thoracic spine managed by total en bloc spondylectomy and denosumab therapy: a case report.
Duan PG; Sheng YH; Deng CH; Tang BY; Yao HQ
BMC Musculoskelet Disord; 2020 Feb; 21(1):105. PubMed ID: 32061254
[TBL] [Abstract][Full Text] [Related]
9. Response to Denosumab in 2 Children With Recurrent Giant Cell Tumor of the Bone With Pulmonary Metastasis.
Reddy K; Ramirez L; Kukreja K; Venkatramani R
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e215-e218. PubMed ID: 31714440
[TBL] [Abstract][Full Text] [Related]
10. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy.
Yonezawa N; Murakami H; Kato S; Takeuchi A; Tsuchiya H
Eur Spine J; 2017 May; 26(Suppl 1):236-242. PubMed ID: 28396950
[TBL] [Abstract][Full Text] [Related]
11. Denosumab does not decrease the risk of lung metastases from bone giant cell tumour.
Tsukamoto S; Mavrogenis AF; Leone G; Righi A; Akahane M; Tanzi P; Kido A; Honoki K; Tanaka Y; Donati DM; Errani C
Int Orthop; 2019 Feb; 43(2):483-489. PubMed ID: 30099641
[TBL] [Abstract][Full Text] [Related]
12. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
Müller DA; Beltrami G; Scoccianti G; Campanacci DA; Franchi A; Capanna R
World J Surg Oncol; 2016 Nov; 14(1):281. PubMed ID: 27809843
[TBL] [Abstract][Full Text] [Related]
13. Conversion in a Resectable Tumor after Denosumab Neoadjuvant in a Large Dorsal Giant Cells Tumor: A Case Report and a Literature Review.
Sereno M; Franco SR; de la Reina L; Campo-Cañaveral de la Cruz JL; Muñoz de Legaría M; Casado Saénz E
Curr Oncol; 2023 Oct; 30(10):9335-9345. PubMed ID: 37887575
[TBL] [Abstract][Full Text] [Related]
14. Morphologic Changes After Denosumab Therapy in Patients with Giant Cell Tumor of the Spine: Report of Four Cases and a Review of the Literature.
Yonezawa N; Murakami H; Demura S; Kato S; Yoshioka K; Takeuchi A; Shinmura K; Yokogawa N; Shimizu T; Oku N; Kitagawa R; Handa M; Tsuchiya H
World Neurosurg; 2019 Jul; 127():38-46. PubMed ID: 30926552
[TBL] [Abstract][Full Text] [Related]
15. Interest of Denosumab for the Treatment of Giant-cells Tumors and Aneurysmal Bone Cysts of the Spine. About Nine Cases.
Dubory A; Missenard G; Domont J; Court C
Spine (Phila Pa 1976); 2016 Jun; 41(11):E654-E660. PubMed ID: 27244112
[TBL] [Abstract][Full Text] [Related]
16. Recommencement of Denosumab for Unresectable Giant Cell Tumor of the Cervical Spine: A Case Report.
Law GW; Yeo NEM; Howe TS; Tan YZ; Tan SB; Siddiqui MMA
Spine (Phila Pa 1976); 2018 May; 43(9):E551-E556. PubMed ID: 29016442
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
Traub F; Singh J; Dickson BC; Leung S; Mohankumar R; Blackstein ME; Razak AR; Griffin AM; Ferguson PC; Wunder JS
Eur J Cancer; 2016 May; 59():1-12. PubMed ID: 26990281
[TBL] [Abstract][Full Text] [Related]
18. Primary thoracic giant cell tumor of bone sensitive to steroids.
Yang H; Im GH; Nielsen GP; Kheterpal A; Schwab JH
Skeletal Radiol; 2018 Oct; 47(10):1431-1435. PubMed ID: 29502130
[TBL] [Abstract][Full Text] [Related]
19. Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial.
Ueda T; Morioka H; Nishida Y; Kakunaga S; Tsuchiya H; Matsumoto Y; Asami Y; Inoue T; Yoneda T
Ann Oncol; 2015 Oct; 26(10):2149-54. PubMed ID: 26205395
[TBL] [Abstract][Full Text] [Related]
20. The role of Denosumab in joint preservation for patients with giant cell tumour of bone.
Perrin DL; Visgauss JD; Wilson DA; Griffin AM; Abdul Razak AR; Ferguson PC; Wunder JS
Bone Joint J; 2021 Jan; 103-B(1):184-191. PubMed ID: 33380180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
